{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:08:01Z","timestamp":1748002081080,"version":"3.37.3"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T00:00:00Z","timestamp":1694908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T00:00:00Z","timestamp":1694908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05453-9","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T16:01:31Z","timestamp":1694966491000},"page":"2167-2174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diabetes mellitus in rheumatic diseases: clinical characteristics and treatment considerations"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5042-1191","authenticated-orcid":false,"given":"Yuliya","family":"Fedorchenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-9442","authenticated-orcid":false,"given":"Khaiyom","family":"Mahmudov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4269-5023","authenticated-orcid":false,"given":"Zhumabek","family":"Abenov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-6918","authenticated-orcid":false,"given":"Marlen","family":"Yessirkepov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,17]]},"reference":[{"issue":"23","key":"5453_CR1","doi-asserted-by":"publisher","first-page":"12338","DOI":"10.3390\/ijerph182312338","volume":"18","author":"J Dadonien\u0117","year":"2021","unstructured":"Dadonien\u0117 J, Charukevi\u010d G, Jasionyt\u0117 G, Sta\u0161kuvien\u0117 K, Miltinien\u0117 D (2021) Mortality in inflammatory rheumatic diseases: lithuanian national registry data and systematic review. Int J Environ Res Public Health 18(23):12338","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"5453_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00296-020-04764-5","volume":"41","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Gasparyan AY, Zimba O (2021) Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic. Rheumatol Int 41(2):243\u2013256","journal-title":"Rheumatol Int"},{"issue":"2","key":"5453_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/nu13020545","volume":"13","author":"M Matsunaga","year":"2021","unstructured":"Matsunaga M, Lim E, Davis J, Chen JJ (2021) Dietary quality associated with self-reported diabetes, osteoarthritis, and rheumatoid arthritis among younger and older US adults: a cross-sectional study using NHANES 2011\u20132016. Nutrients 13(2):545","journal-title":"Nutrients"},{"issue":"1","key":"5453_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08916934.2021.1995860","volume":"55","author":"R Kong","year":"2022","unstructured":"Kong R, Sun L, Li H, Wang D (2022) The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease. Autoimmunity 55(1):1\u20137","journal-title":"Autoimmunity"},{"issue":"12","key":"5453_CR5","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/biom9120850","volume":"9","author":"S Ding","year":"2019","unstructured":"Ding S, Xu S, Ma Y, Liu G, Jang H, Fang J (2019) Modulatory mechanisms of the NLRP3 inflammasomes in diabetes. Biomolecules 9(12):850","journal-title":"Biomolecules"},{"issue":"12","key":"5453_CR6","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1007\/s10067-022-06365-y","volume":"41","author":"P Mehta","year":"2022","unstructured":"Mehta P, Gasparyan AY, Zimba O, Kitas GD, Yessirkepov M (2022) Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses. Clin Rheumatol 41(12):3897\u20133913","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5453_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00296-021-05083-z","volume":"42","author":"M Szab\u0142owski","year":"2022","unstructured":"Szab\u0142owski M, Okruszko MA, Pochodowicz K, Abramowicz P, Konstantynowicz J, Bossowski A et al (2022) Coincidence of juvenile idiopathic arthritis and type 1 diabetes: a case-based review. Rheumatol Int 42(2):371\u2013378","journal-title":"Rheumatol Int"},{"issue":"12","key":"5453_CR8","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1136\/annrheumdis-2020-218296","volume":"79","author":"JL Pablos","year":"2020","unstructured":"Pablos JL, Galindo M, Carmona L, Lled\u00f3 A, Retuerto M, Blanco R et al (2020) Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Ann Rheum Dis 79(12):1544\u20131549","journal-title":"Ann Rheum Dis"},{"key":"5453_CR9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417","journal-title":"Rheumatol Int"},{"issue":"4","key":"5453_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jbspin.2016.09.001","volume":"84","author":"J Nicolau","year":"2017","unstructured":"Nicolau J, Lequerr\u00e9 T, Bacquet H, Vittecoq O (2017) Rheumatoid arthritis, insulin resistance, and diabetes. Joint Bone Spine 84(4):411\u2013416","journal-title":"Joint Bone Spine"},{"issue":"4","key":"5453_CR11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.semarthrit.2020.04.005","volume":"50","author":"W Xie","year":"2020","unstructured":"Xie W, Yang X, Ji L, Zhang Z (2020) Incident diabetes associated with hydroxychloroquine, methotrexate, biologics and glucocorticoids in rheumatoid arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 50(4):598\u2013607","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"5453_CR12","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.3390\/jcm12062148","volume":"12","author":"F Cacciapaglia","year":"2023","unstructured":"Cacciapaglia F, Spinelli FR, Bartoloni E, Bugatti S, Erre GL, Fornaro M et al (2023) Clinical features of diabetes mellitus on rheumatoid arthritis: data from the cardiovascular obesity and rheumatic disease (CORDIS) study group. J Clin Med 12(6):2148","journal-title":"J Clin Med"},{"issue":"3","key":"5453_CR13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/msc.1625","volume":"20","author":"MJ Roberts","year":"2022","unstructured":"Roberts MJ, Leonard AN, Bishop NC, Moorthy A (2022) Lifestyle modification and inflammation in people with axial spondyloarthropathy-A scoping review. Musculoskeletal Care 20(3):516\u2013528","journal-title":"Musculoskeletal Care"},{"issue":"21","key":"5453_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010865","volume":"97","author":"A Emamifar","year":"2018","unstructured":"Emamifar A, Jensen Hansen IM (2018) The influence of thyroid diseases, diabetes mellitus, primary hyperparathyroidism, vitamin B12 deficiency and other comorbid autoimmune diseases on treatment outcome in patients with rheumatoid arthritis: an exploratory cohort study. Medicine (Baltimore) 97(21):e10865","journal-title":"Medicine (Baltimore)"},{"key":"5453_CR15","doi-asserted-by":"publisher","first-page":"8617467","DOI":"10.1155\/2022\/8617467","volume":"2022","author":"W Li","year":"2022","unstructured":"Li W, Bi S, Liang Y, Zhu H (2022) Construction of rheumatoid arthritis risk prediction and medical image applications from rheumatoid factor levels. Comput Math Methods Med 2022:8617467","journal-title":"Comput Math Methods Med"},{"issue":"4","key":"5453_CR16","first-page":"310","volume":"42","author":"A Emamifar","year":"2017","unstructured":"Emamifar A, Levin K, Jensen Hansen IM (2017) Patients with newly diagnosed rheumatoid arthritis are at increased risk of diabetes mellitus: an observational cohort study. Acta Reumatol Port 42(4):310\u2013317","journal-title":"Acta Reumatol Port"},{"issue":"1","key":"5453_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13075-018-1771-0","volume":"20","author":"S Panopoulos","year":"2018","unstructured":"Panopoulos S, Tektonidou M, Drosos AA, Liossis SN, Dimitroulas T, Garyfallos A et al (2018) Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study. Arthritis Res Ther 20(1):267","journal-title":"Arthritis Res Ther"},{"key":"5453_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejim.2021.10.001","volume":"96","author":"F Cacciapaglia","year":"2022","unstructured":"Cacciapaglia F, Spinelli FR, Piga M, Erre GL, Sakellariou G, Manfredi A et al (2022) Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: data from the cardiovascular obesity and rheumatic disease (CORDIS) study group. Eur J Intern Med 96:60\u201365","journal-title":"Eur J Intern Med"},{"issue":"8","key":"5453_CR19","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1093\/rheumatology\/keaa810","volume":"60","author":"J Avouac","year":"2021","unstructured":"Avouac J, Elhai M, Forien M, Sellam J, Eymard F, Molto A et al (2021) Influence of inflammatory and non-inflammatory rheumatic disorders on the clinical and biological profile of type-2 diabetes. Rheumatology (Oxford) 60(8):3598\u20133606","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5453_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/joim.12743","volume":"284","author":"I Arias de la Rosa","year":"2018","unstructured":"Arias de la Rosa I, Escudero-Contreras A, Rodr\u00edguez-Cuenca S, Ruiz-Ponce M, Jim\u00e9nez-G\u00f3mez Y, Ruiz-Lim\u00f3n P et al (2018) Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues. J Intern Med 284(1):61\u201377","journal-title":"J Intern Med"},{"issue":"5","key":"5453_CR21","doi-asserted-by":"publisher","first-page":"995","DOI":"10.55563\/clinexprheumatol\/5r53em","volume":"39","author":"P Ruscitti","year":"2021","unstructured":"Ruscitti P, Cipriani P, Liakouli V, Iacono D, Pantano I, Margiotta DPE et al (2021) Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study. Clin Exp Rheumatol 39(5):995\u20131002","journal-title":"Clin Exp Rheumatol"},{"issue":"34","key":"5453_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007896","volume":"96","author":"P Ruscitti","year":"2017","unstructured":"Ruscitti P, Ursini F, Cipriani P, Ciccia F, Liakouli V, Carubbi F et al (2017) Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: results from a cross-sectional study. Medicine (Baltimore) 96(34):e7896","journal-title":"Medicine (Baltimore)"},{"key":"5453_CR23","doi-asserted-by":"publisher","first-page":"205031212210880","DOI":"10.1177\/20503121221088088","volume":"10","author":"N Eddy Warman","year":"2022","unstructured":"Eddy Warman N, Baharuddin H, Abdul Rahman TH, Ismail N, Ch\u2019Ng SS, Rosman A, Abdul Ghani R (2022) High prevalence of undiagnosed impaired glucose tolerance in patients with rheumatoid arthritis. SAGE Open Med 10:20503121221088090","journal-title":"SAGE Open Med"},{"issue":"10","key":"5453_CR24","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.36740\/WLek202210103","volume":"75","author":"UA Al-Sari","year":"2022","unstructured":"Al-Sari UA (2022) Rheumatoid arthritis as a predisposing factor for increased risk of diabetes mellitus incidence. Wiad Lek 75(10):2329\u20132333. https:\/\/doi.org\/10.36740\/WLek202210103","journal-title":"Wiad Lek"},{"issue":"7","key":"5453_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028011","volume":"9","author":"G Li","year":"2019","unstructured":"Li G, Chi W, Bai B, Li Y, Wei T, Fu L (2019) Dose\u2212response associations between metabolic indexes and the risk of comorbid type 2 diabetes mellitus among rheumatoid arthritis patients from Northern China: a case\u2212control study. BMJ Open 9(7):e028011","journal-title":"BMJ Open"},{"issue":"1","key":"5453_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.31138\/mjr.29.1.27","volume":"29","author":"K Thomas","year":"2018","unstructured":"Thomas K, Lazarini A, Kaltsonoudis E, Drosos A, Papalopoulos I, Sidiropoulos P et al (2018) Multicenter cross-sectional study of patients with rheumatoid arthritis in Greece: results from a cohort of 2.491 patients. Mediterr J Rheumatol 29(1):27\u201337","journal-title":"Mediterr J Rheumatol"},{"issue":"6","key":"5453_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s40259-022-00561-7","volume":"36","author":"C Di Muzio","year":"2022","unstructured":"Di Muzio C, Cipriani P, Ruscitti P (2022) Rheumatoid arthritis treatment options and type 2 diabetes: unravelling the association. BioDrugs 36(6):673\u2013685","journal-title":"BioDrugs"},{"issue":"6","key":"5453_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-042246","volume":"11","author":"SK Paul","year":"2021","unstructured":"Paul SK, Montvida O, Best JH, Gale S, Peth\u00f6-Schramm A, Sarsour K (2021) Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis. BMJ Open 11(6):e042246","journal-title":"BMJ Open"},{"key":"5453_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/OARRR.S302679","volume":"13","author":"A Lurati","year":"2021","unstructured":"Lurati A, Laria A, Mazzocchi D, Re KA, Marrazza MG, Faggioli PM et al (2021) Improvement of HbA1c in patients with type 2 diabetes mellitus and rheumatoid arthritis treated with bDMARDs. Open Access Rheumatol 13:73\u201378","journal-title":"Open Access Rheumatol"},{"issue":"4","key":"5453_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/acr2.11124","volume":"2","author":"RJ Desai","year":"2020","unstructured":"Desai RJ, Dejene S, Jin Y, Liu J, Kim SC (2020) Comparative risk of diabetes mellitus in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying drugs: a cohort study. ACR Open Rheumatol 2(4):222\u2013231","journal-title":"ACR Open Rheumatol"},{"key":"5453_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105216","volume":"161","author":"C Lin","year":"2020","unstructured":"Lin C, Ji H, Cai X, Yang W, Lv F, Ji L (2020) The association between the biological disease-modifying anti-rheumatic drugs and the incidence of diabetes: a systematic review and meta-analysis. Pharmacol Res 161:105216","journal-title":"Pharmacol Res"},{"issue":"8","key":"5453_CR32","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.3390\/jcm11082109","volume":"11","author":"SH Nam","year":"2022","unstructured":"Nam SH, Kim M, Kim YJ, Ahn SM, Hong S, Lee CK et al (2022) Risk of new-onset diabetes mellitus associated with antirheumatic drugs in patients with rheumatoid arthritis: a nationwide population study. J Clin Med 11(8):2109","journal-title":"J Clin Med"},{"issue":"1","key":"5453_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.rdc.2015.08.004","volume":"42","author":"J Youssef","year":"2015","unstructured":"Youssef J, Novosad SA, Winthrop KL (2015) Infection risk and safety of corticosteroid use. Rheum Dis Clin North Am 42(1):157\u2013176","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"5453_CR34","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/art.39537","volume":"68","author":"M Movahedi","year":"2016","unstructured":"Movahedi M, Beauchamp ME, Abrahamowicz M, Ray DW, Michaud K, Pedro S et al (2016) Risk of incident diabetes mellitus associated with the dosage and duration of oral glucocorticoid therapy in patients with rheumatoid arthritis. Arthritis Rheumatol 68(5):1089\u20131098","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"5453_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210459","volume":"14","author":"S Lillegraven","year":"2019","unstructured":"Lillegraven S, Greenberg JD, Reed GW, Saunders K, Curtis JR, Harrold L et al (2019) Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis. PLoS ONE 14(1):e0210459","journal-title":"PLoS ONE"},{"key":"5453_CR36","doi-asserted-by":"publisher","first-page":"8821978","DOI":"10.1155\/2020\/8821978","volume":"2020","author":"JF Huang","year":"2020","unstructured":"Huang JF, Wu QN, Zheng XQ, Sun XL, Wu CY, Wang XB et al (2020) The characteristics and mortality of osteoporosis, osteomyelitis, or rheumatoid arthritis in the diabetes population: a retrospective study. Int J Endocrinol 2020:8821978","journal-title":"Int J Endocrinol"},{"issue":"1","key":"5453_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41927-021-00181-8","volume":"5","author":"RE Costello","year":"2021","unstructured":"Costello RE, Marsden A, Movahedi M, Lunt M, Humphreys JH, Emsley R et al (2021) Correction to: The effect of glucocorticoid therapy on mortality in patients with rheumatoid arthritis and concomitant type II diabetes: a retrospective cohort study. BMC Rheumatol 5(1):11","journal-title":"BMC Rheumatol"},{"key":"5453_CR38","doi-asserted-by":"publisher","first-page":"7987529","DOI":"10.1155\/2019\/7987529","volume":"2019","author":"CY Lee","year":"2019","unstructured":"Lee CY, Tai CJ, Tsai YF, Kuan YH, Lee CH, Huang KH (2019) Prescribing trend of antirheumatic drugs in taiwan and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study. Biomed Res Int 2019:7987529","journal-title":"Biomed Res Int"},{"issue":"3","key":"5453_CR39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/acr.24866","volume":"75","author":"G Ozen","year":"2023","unstructured":"Ozen G, Dell\u2019Aniello S, Pedro S, Michaud K, Suissa S (2023) Reduction of cardiovascular disease and mortality versus risk of new-onset diabetes mellitus with statin use in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 75(3):597\u2013607","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"5453_CR40","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200485R","volume":"36","author":"K Li","year":"2022","unstructured":"Li K, Ji X, Seeley R, Lee WC, Shi Y, Song F et al (2022) Impaired glucose metabolism underlies articular cartilage degeneration in osteoarthritis. FASEB J 36(6):e22377","journal-title":"FASEB J"},{"issue":"2","key":"5453_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.joca.2020.09.010","volume":"29","author":"L Kuusalo","year":"2021","unstructured":"Kuusalo L, Felson DT, Wang N, Lewis CE, Torner J, Nevitt MC et al (2021) Metabolic osteoarthritis - relation of diabetes and cardiovascular disease with knee osteoarthritis. Osteoarthr Cartil 29(2):230\u2013234","journal-title":"Osteoarthr Cartil"},{"issue":"11","key":"5453_CR42","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1007\/s00125-018-4703-2","volume":"61","author":"T Kendzerska","year":"2018","unstructured":"Kendzerska T, King LK, Lipscombe L, Croxford R, Stanaitis I, Hawker GA (2018) The impact of hip and knee osteoarthritis on the subsequent risk of incident diabetes: a population-based cohort study. Diabetologia 61(11):2290\u20132299","journal-title":"Diabetologia"},{"issue":"6","key":"5453_CR43","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/ije\/dyy187","volume":"47","author":"A Mendy","year":"2018","unstructured":"Mendy A, Park J, Vieira ER (2018) Osteoarthritis and risk of mortality in the USA: a population-based cohort study. Int J Epidemiol 47(6):1821\u20131829","journal-title":"Int J Epidemiol"},{"issue":"3","key":"5453_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.rehab.2016.04.002","volume":"59","author":"M Duclos","year":"2016","unstructured":"Duclos M (2016) Osteoarthritis, obesity and type 2 diabetes: the weight of waist circumference. Ann Phys Rehabil Med 59(3):157\u2013160","journal-title":"Ann Phys Rehabil Med"},{"key":"5453_CR45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.diabres.2016.10.021","volume":"122","author":"A Courties","year":"2016","unstructured":"Courties A, Sellam J (2016) Osteoarthritis and type 2 diabetes mellitus: what are the links? Diabetes Res Clin Pract 122:198\u2013206","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"5453_CR46","doi-asserted-by":"publisher","first-page":"e000736","DOI":"10.1136\/bmjdrc-2019-000736","volume":"7","author":"MC Castano Betancourt","year":"2019","unstructured":"Castano Betancourt MC, Morais CL, Vannucci Nunes Lipay M, Arag\u00e3o J, de Azevedo E, Souza Munhoz M, Gomes Machado E et al (2019) Gender differences in the effect of diabetes mellitus and its treatment on osteoarthritic pain. BMJ Open Diabetes Res Care 7(1):e000736","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"5453_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.joca.2016.08.003","volume":"25","author":"GA Hawker","year":"2017","unstructured":"Hawker GA, Croxford R, Bierman AS, Harvey P, Ravi B, Kendzerska T et al (2017) Osteoarthritis-related difficulty walking and risk for diabetes complications. Osteoarthr Cartil 25(1):67\u201375","journal-title":"Osteoarthr Cartil"},{"issue":"5","key":"5453_CR48","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jdiacomp.2016.02.016","volume":"30","author":"MF Williams","year":"2016","unstructured":"Williams MF, London DA, Husni EM, Navaneethan S, Kashyap SR (2016) Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J Diabetes Complic 30(5):944\u2013950","journal-title":"J Diabetes Complic"},{"issue":"1","key":"5453_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191242","volume":"13","author":"CH Lu","year":"2018","unstructured":"Lu CH, Chung CH, Lee CH, Hsieh CH, Hung YJ, Lin FH et al (2018) Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: a nationwide, retrospective, matched-cohort study in Taiwan. PLoS ONE 13(1):e0191242","journal-title":"PLoS ONE"},{"issue":"19","key":"5453_CR50","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.3390\/cells11193012","volume":"11","author":"M He","year":"2022","unstructured":"He M, Lu B, Opoku M, Zhang L, Xie W, Jin H et al (2022) Metformin prevents or delays the development and progression of osteoarthritis: new insight and mechanism of action. Cells 11(19):3012","journal-title":"Cells"},{"key":"5453_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.908831","volume":"13","author":"N Gao","year":"2022","unstructured":"Gao N, Kong M, Li X, Wei D, Zhu X, Hong Z et al (2022) Systemic lupus erythematosus and cardiovascular disease: a mendelian randomization study. Front Immunol 13:908831","journal-title":"Front Immunol"},{"issue":"51","key":"5453_CR52","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032520","volume":"101","author":"YJ Lin","year":"2022","unstructured":"Lin YJ, Chien CC, Ho CH, Chen HA, Chen CY (2022) Increased risk of type 2 diabetes in patients with systemic lupus erythematosus: a nationwide cohort study in Taiwan. Medicine (Baltimore) 101(51):e32520","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"5453_CR53","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s10067-018-4169-0","volume":"37","author":"LL Castro","year":"2018","unstructured":"Castro LL, Lanna CCD, Ribeiro ALP, Telles RW (2018) Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus. Clin Rheumatol 37(10):2693\u20132698","journal-title":"Clin Rheumatol"},{"issue":"4","key":"5453_CR54","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2174\/1871530322666220908154253","volume":"23","author":"M Garc\u00eda-Carrasco","year":"2023","unstructured":"Garc\u00eda-Carrasco M, Mendoza-Pinto C, Mungu\u00eda-Realpozo P, Etchegaray-Morales I, V\u00e9lez-Pelcastre SK, M\u00e9ndez-Mart\u00ednez S et al (2023) Insulin resistance and diabetes mellitus in patients with systemic lupus erythematosus. Endocr Metab Immune Disord Drug Targets 23(4):503\u2013514","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"8","key":"5453_CR55","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1093\/rheumatology\/keaa874","volume":"60","author":"A Garc\u00eda-Dorta","year":"2021","unstructured":"Garc\u00eda-Dorta A, Quevedo-Abeledo JC, Rua-Figueroa \u00cd, de Vera-Gonz\u00e1lez AM, Gonz\u00e1lez-Delgado A, Medina-Vega L et al (2021) Beta-cell function is disrupted in patients with systemic lupus erythematosus. Rheumatology (Oxford) 60(8):3826\u20133833","journal-title":"Rheumatology (Oxford)"},{"key":"5453_CR56","doi-asserted-by":"publisher","first-page":"4655804","DOI":"10.1155\/2022\/4655804","volume":"2022","author":"JC Alvarez-Payares","year":"2022","unstructured":"Alvarez-Payares JC, Ribero D, Rodr\u00edguez L, Builes CE, Prieto C, Arango C et al (2022) Late systemic lupus erythematosus-associated insulin resistance syndrome: a rare cause of de novo diabetes mellitus. Case Rep Med 2022:4655804","journal-title":"Case Rep Med"},{"issue":"2","key":"5453_CR57","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s13340-021-00544-z","volume":"13","author":"S Hanai","year":"2021","unstructured":"Hanai S, Kobayashi Y, Ichijo M, Ito R, Kobayashi K, Nakagomi D (2021) Antidiabetic effects of hydroxychloroquine in two Japanese patients with systemic lupus erythematosus. Diabetol Int 13(2):447\u2013451","journal-title":"Diabetol Int"},{"issue":"5","key":"5453_CR58","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/1756-185X.12474","volume":"18","author":"SS Shaharir","year":"2015","unstructured":"Shaharir SS, Gafor AH, Said MS, Kong NC (2015) Steroid-induced diabetes mellitus in systemic lupus erythematosus patients: analysis from a Malaysian multi-ethnic lupus cohort. Int J Rheum Dis 18(5):541\u2013547","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"5453_CR59","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/rheumatology\/keu451","volume":"54","author":"YM Chen","year":"2015","unstructured":"Chen YM, Lin CH, Lan TH, Chen HH, Chang SN, Chen YH et al (2015) Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study. Rheumatology (Oxford) 54(7):1244\u20131249","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"5453_CR60","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s40261-017-0518-z","volume":"37","author":"S Sciascia","year":"2017","unstructured":"Sciascia S, Mompean E, Radin M, Roccatello D, Cuadrado MJ (2017) Rate of adverse effects of medium- to high-dose glucocorticoid therapy in systemic lupus erythematosus: a systematic review of randomized control trials. Clin Drug Investig 37(6):519\u2013524","journal-title":"Clin Drug Investig"},{"issue":"5","key":"5453_CR61","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/acr.24147","volume":"73","author":"S Salmasi","year":"2021","unstructured":"Salmasi S, Sayre EC, Antonio Avi\u00f1a-Zubieta J, Esdaile JM, De Vera MA (2021) Adherence to antimalarial therapy and risk of type 2 diabetes mellitus among patients with systemic lupus erythematosus: a population-based study. Arthritis Care Res (Hoboken) 73(5):702\u2013706","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5453_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.deman.2022.100089","volume":"8","author":"D Levinson","year":"2022","unstructured":"Levinson D, Abugroun A, Osinski K (2022) Hydroxychloroquine lowers the risk for diabetes mellitus in patients with systemic lupus erythematosus. Diabetes Epidemiol Manag 8:100089","journal-title":"Diabetes Epidemiol Manag"},{"issue":"1","key":"5453_CR63","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.1038\/s41598-018-24529-2","volume":"8","author":"MY Jiang","year":"2018","unstructured":"Jiang MY, Hwang JC, Feng IJ (2018) Impact of diabetes mellitus on the risk of end-stage renal disease in patients with systemic lupus erythematosus. Sci Rep 8(1):6008","journal-title":"Sci Rep"},{"key":"5453_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25091","author":"RB Hansen","year":"2023","unstructured":"Hansen RB, Falasinnu T, Faurschou M, Jacobsen S, Simard JF (2023) Risk of end-stage renal disease in patients with systemic lupus erythematosus and diabetes mellitus: a Danish nationwide cohort study. Arthritis Care Res (Hoboken). https:\/\/doi.org\/10.1002\/acr.25091","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5453_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.640618","volume":"12","author":"SY Gau","year":"2021","unstructured":"Gau SY, Leong PY, Lin CL, Tsou HK, Wei JC (2021) Higher Risk for sj\u00f6gren\u2019s syndrome in patients with fibromyalgia: a nationwide population-based cohort study. Front Immunol 12:640618","journal-title":"Front Immunol"},{"issue":"10","key":"5453_CR66","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/1756-185X.14400","volume":"25","author":"YJ Su","year":"2022","unstructured":"Su YJ, Leong PY, Wang YH, Wei JC (2022) Sj\u00f6gren syndrome is a hidden contributor of macrovascular and microvascular complications in patients with type 2 diabetes. Int J Rheum Dis 25(10):1176\u20131185","journal-title":"Int J Rheum Dis"},{"issue":"10","key":"5453_CR67","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/qjmed\/hcz112","volume":"112","author":"TH Chen","year":"2019","unstructured":"Chen TH, Lai TY, Wang YH, Chiou JY, Hung YM, Wei JC (2019) Hydroxychloroquine was associated with reduced risk of new-onset diabetes mellitus in patients with Sj\u00f6gren syndrome. QJM 112(10):757\u2013762","journal-title":"QJM"},{"issue":"13","key":"5453_CR68","doi-asserted-by":"publisher","first-page":"7231","DOI":"10.3390\/ijms22137231","volume":"22","author":"J Kim","year":"2021","unstructured":"Kim J, Kim YS, Park SH (2021) Metformin as a treatment strategy for Sj\u00f6gren\u2019s syndrome. Int J Mol Sci 22(13):7231","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5453_CR69","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/mr\/roab096","volume":"32","author":"Y Matsubara","year":"2022","unstructured":"Matsubara Y, Nakamura Y, Tamura N, Kameda H, Otomo K, Kishimoto M et al (2022) A nationwide questionnaire survey on the prevalence of ankylosing spondylitis and non-radiographic axial spondyloarthritis in Japan. Mod Rheumatol 32(5):960\u2013967","journal-title":"Mod Rheumatol"},{"key":"5453_CR70","doi-asserted-by":"publisher","first-page":"1759720X2110337","DOI":"10.1177\/1759720X211033755","volume":"13","author":"I Ferraz-Amaro","year":"2021","unstructured":"Ferraz-Amaro I, Rueda-Gotor J, Genre F, Corrales A, Blanco R, Portilla V et al (2021) Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis. Ther Adv Musculoskelet Dis 13:1759720X211033755","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"5453_CR71","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00296-013-2927-5","volume":"34","author":"HH Chen","year":"2014","unstructured":"Chen HH, Yeh SY, Chen HY, Lin CL, Sung FC, Kao CH (2014) Ankylosing spondylitis and other inflammatory spondyloarthritis increase the risk of developing type 2 diabetes in an Asian population. Rheumatol Int 34(2):265\u2013270. https:\/\/doi.org\/10.1007\/s00296-013-2927-5","journal-title":"Rheumatol Int"},{"issue":"8","key":"5453_CR72","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1136\/annrheumdis-2015-207688","volume":"75","author":"S Exarchou","year":"2016","unstructured":"Exarchou S, Lie E, Lindstr\u00f6m U, Askling J, Forsblad-d\u2019Elia H, Turesson C et al (2016) Mortality in ankylosing spondylitis: results from a nationwide population-based study. Ann Rheum Dis 75(8):1466\u20131472","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"5453_CR73","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4239\/wjd.v12.i3.238","volume":"12","author":"CR Wang","year":"2021","unstructured":"Wang CR, Tsai HW (2021) Anti- and non-tumor necrosis factor-\u03b1-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. World J Diabetes 12(3):238\u2013260","journal-title":"World J Diabetes"},{"key":"5453_CR74","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2147\/TCRM.S130666","volume":"13","author":"HH Chen","year":"2017","unstructured":"Chen HH, Chen DY, Lin CC, Chen YM, Lai KL, Lin CH (2017) Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis\/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients. Ther Clin Risk Manag 13:583\u2013592","journal-title":"Ther Clin Risk Manag"},{"key":"5453_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.151956","volume":"52","author":"TB van der Houwen","year":"2022","unstructured":"van der Houwen TB, van Hagen PM, van Laar JAM (2022) Immunopathogenesis of Beh\u00e7et\u2019s disease and treatment modalities. Semin Arthritis Rheum 52:151956","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"5453_CR76","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s10067-019-04570-w","volume":"38","author":"TA Gheita","year":"2019","unstructured":"Gheita TA, El-Latif EA, El-Gazzar II, Samy N, Hammam N, Abdel Noor RA et al (2019) Beh\u00e7et\u2019s disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature. Clin Rheumatol 38(9):2565\u20132575","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5453_CR77","volume":"15","author":"F Alharthy","year":"2023","unstructured":"Alharthy F, Almaqati AS, Alsulami S, Ahmad A (2023) Beh\u00e7et\u2019s disease in Saudi Arabia: clinical and demographic characteristics. Cureus 15(2):e34867","journal-title":"Cureus"},{"issue":"1","key":"5453_CR78","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000514634","volume":"238","author":"JH Jung","year":"2022","unstructured":"Jung JH, Han KD, Lee YB, Park YG (2022) Beh\u00e7et\u2019s disease is associated with multiple sclerosis and rheumatoid arthritis: a Korean population-based study. Dermatology 238(1):86\u201391","journal-title":"Dermatology"},{"key":"5453_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01044-x","author":"T Chen","year":"2023","unstructured":"Chen T, Shao X, Li H, Chen Y, Liu L, Zhong J, Chen J (2023) Association of Beh\u00e7et\u2019s disease with the risk of metabolic syndrome and its components: a systematic review and meta-analysis. Clin Exp Med. https:\/\/doi.org\/10.1007\/s10238-023-01044-x","journal-title":"Clin Exp Med"},{"issue":"SI-2","key":"5453_CR80","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3906\/sag-2008-11","volume":"50","author":"A Tufan","year":"2020","unstructured":"Tufan A, Lachmann HJ (2020) Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review. Turk J Med Sci 50(SI-2):1591\u20131610","journal-title":"Turk J Med Sci"},{"issue":"1","key":"5453_CR81","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13052-021-01077-6","volume":"47","author":"MF Gicchino","year":"2021","unstructured":"Gicchino MF, Iafusco D, Zanfardino A, Del Giudice EM, Olivieri AN (2021) A case report of a boy suffering from type 1 diabetes mellitus and familial Mediterranean fever. Ital J Pediatr 47(1):127","journal-title":"Ital J Pediatr"},{"issue":"1","key":"5453_CR82","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejmg.2014.10.005","volume":"58","author":"GM Anwar","year":"2015","unstructured":"Anwar GM, Fouad HM, Abd El-Hamid A, Mahmoud F, Musa N, Lotfi H et al (2015) A study of familial Mediterranean Fever (MEFV) gene mutations in Egyptian children with type 1 diabetes mellitus. Eur J Med Genet 58(1):31\u201334","journal-title":"Eur J Med Genet"},{"issue":"2","key":"5453_CR83","first-page":"183","volume":"51","author":"F Ba\u015f","year":"2009","unstructured":"Ba\u015f F, Kabata\u015f-Eryilmaz S, G\u00fcn\u00f6z H, Darendeliler F, K\u00fc\u00e7\u00fckemre B, Bundak R et al (2009) Type 1 diabetes mellitus associated with autoimmune thyroid disease, celiac disease and familial Mediterranean fever: case report. Turk J Pediatr 51(2):183\u2013186","journal-title":"Turk J Pediatr"},{"issue":"8","key":"5453_CR84","first-page":"1567","volume":"40","author":"F Kharouf","year":"2022","unstructured":"Kharouf F, Tsemach-Toren T, Ben-Chetrit E (2022) IL-1 inhibition in familial Mediterranean fever: clinical outcomes and expectations. Clin Exp Rheumatol 40(8):1567\u20131574","journal-title":"Clin Exp Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05453-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05453-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05453-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T07:04:10Z","timestamp":1697699050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05453-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,17]]},"references-count":84,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5453"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05453-9","relation":{},"ISSN":["1437-160X"],"issn-type":[{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2023,9,17]]},"assertion":[{"value":"11 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None\u00a0declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}